Health-related quality of life in pediatric and adolescent patients with transfusion-dependent ß-thalassemia in upper Egypt (single center study)

[1] Rund D(2005)Beta-thalassemia N Engl J Med 353 1135-1146

[2] Rachmilewitz E(2006)Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial Haematologica 91 1193-1202

[3] Voskaridou E(2004)New insights into the pathophysiology and management of osteoporosis in patients with beta thalassemia Br J Haematol 127 127-139

[4] Anagnostopoulos A(2005)Osteoporosis in beta-thalassemia: clinical and genetic aspects Ann N Y Acad Sci 1054 451-456

[5] Konstantopoulos K(2008)Assessment of puberty in relation to L-carnitine and hormonal replacement therapy in β-thalassemia patients. Tropical Pediatrics 54 375-381

[6] Voskaridou E(2001)Living a “normal life”: young people coping with thalassemia major or sickle cell disorder Soc Sci Med 53 615-626

[7] Terpos E(2012)Health-related quality of life in middle eastern children with beta-thalassemia BMC Blood Disord 12 6-2106

[8] Origa R(2002)The PedsQLin pediatric cancer: reliability and validity of the pediatric quality of life inventory generic core scales, multidimensional fatigue scale, and cancer module Cancer 94 2090-215

[9] Fiumana E(2006)The PedsQL 4.0 as a school population measure: feasibility, reliability, and validity Qual Life Res 15 203-282

[10] Gamberini MR(2005)Quality of life in Thalassaemia Annals of the New York Academy of Science 1054 273-461

[1] Rund D(2005)Beta-thalassemia N Engl J Med 353 1135-1146

[2] Rachmilewitz E(2006)Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial Haematologica 91 1193-1202

[3] Voskaridou E(2004)New insights into the pathophysiology and management of osteoporosis in patients with beta thalassemia Br J Haematol 127 127-139

[4] Anagnostopoulos A(2005)Osteoporosis in beta-thalassemia: clinical and genetic aspects Ann N Y Acad Sci 1054 451-456

[5] Konstantopoulos K(2008)Assessment of puberty in relation to L-carnitine and hormonal replacement therapy in β-thalassemia patients. Tropical Pediatrics 54 375-381

[6] Voskaridou E(2001)Living a “normal life”: young people coping with thalassemia major or sickle cell disorder Soc Sci Med 53 615-626

[7] Terpos E(2012)Health-related quality of life in middle eastern children with beta-thalassemia BMC Blood Disord 12 6-2106

[8] Origa R(2002)The PedsQLin pediatric cancer: reliability and validity of the pediatric quality of life inventory generic core scales, multidimensional fatigue scale, and cancer module Cancer 94 2090-215

[9] Fiumana E(2006)The PedsQL 4.0 as a school population measure: feasibility, reliability, and validity Qual Life Res 15 203-282

[10] Gamberini MR(2005)Quality of life in Thalassaemia Annals of the New York Academy of Science 1054 273-461